Watch OM. Know when insiders buy.
One email the day a filing lands. Free.
OM
Outset Medical, Inc.
4.05
−0.17 −4.03%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
70
PASS · insiders 79, shorts 60
Insiders, 90 days
+$870K
net buying · 2 buys, 0 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $76.1MP/E —DIV YIELD —FCF YIELD -51.07%REV TTM $117.8M −1.3%NET INCOME −$74.3MNET DEBT $61.2M52W 2.96 – 15.27SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $31.6M | +0.7% | 42.0% | −$15.7M | −$18M | — | -0.97 | −$9.6M | $111K | −$9.7M | Aug 6 |
| Q1 2026 · Mar 31 | $27.9M | −6.3% | 43.4% | −$16.9M | −$19M | — | -1.03 | −$12.8M | $65K | −$12.9M | Aug 6 |
| Q4 2025 · Dec 31derived | $28.9M | −2.0% | 42.4% | −$17.6M | −$19.5M | — | -1.00 | −$9.5M | $223K | −$9.7M | Feb 13 |
| Q3 2025 · Sep 30 | $29.4M | +2.7% | 39.4% | −$15.8M | −$17.8M | — | -1.00 | −$6.3M | $160K | −$6.5M | Nov 10 |
| Q2 2025 · Jun 30 | $31.4M | +14.7% | 37.8% | −$16.9M | −$18.5M | — | -1.04 | −$4.8M | $292K | −$5.1M | Aug 6 |
| Q1 2025 · Mar 31 | $29.8M | +5.6% | 37.2% | −$16.4M | −$25.8M | — | -3.66 | −$25.7M | $123K | −$25.8M | Aug 6 |
| Q4 2024 · Dec 31derived | $29.5M | −3.4% | 36.5% | −$21.9M | −$25.6M | — | -7.25 | −$16.5M | $43K | −$16.5M | Feb 13 |
| Q3 2024 · Sep 30 | $28.7M | −5.6% | 34.3% | −$23.8M | −$27.9M | — | -8.02 | −$20.6M | $395K | −$21M | Nov 10 |
| Q2 2024 · Jun 30 | $27.4M | — | 35.7% | −$30.8M | −$34.5M | — | -9.96 | −$33.3M | $120K | −$33.5M | Nov 10 |
| Q1 2024 · Mar 31 | $28.2M | — | 29.2% | −$36.9M | −$39.9M | — | -11.77 | −$45.9M | $354K | −$46.3M | Nov 10 |
| Q4 2023 · Dec 31derived | $30.5M | — | 25.3% | −$37.4M | −$38.6M | — | -49.56 | −$24.4M | $1.1M | −$25.5M | Feb 13 |
| Q3 2023 · Sep 30 | $30.4M | — | 23.6% | −$45.5M | −$46.2M | — | -0.93 | −$34M | $782K | −$34.8M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $119.5M | 39.1% | −$66.7M | −$81.7M | -68.3% | -5.37 | −$46.3M | $798K | −$47.1M | — | — |
| FY2024 · to Dec 31 | $113.7M | 33.9% | −$113.4M | −$128M | -112.6% | -36.96 | −$116.3M | $912K | −$117.2M | — | — |
| FY2023 · to Dec 31 | $130.4M | 22.2% | −$169.8M | −$172.8M | -132.5% | -52.28 | −$131.4M | $3.4M | −$134.8M | — | — |
| FY2022 · to Dec 31 | $115.4M | 15.5% | −$161M | −$163M | -141.2% | -3.38 | −$145.7M | $8.3M | −$154.1M | — | — |
| FY2021 · to Dec 31 | $102.6M | 7.4% | −$130.5M | −$131.9M | -128.6% | -2.89 | −$130.3M | $3.1M | −$133.4M | — | — |
| FY2020 · to Dec 31 | $49.9M | -26.1% | −$117.5M | −$121.5M | -243.3% | -4.85 | −$99M | $9.1M | −$108.1M | — | — |
Every number comes from Outset Medical, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.